Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Maureen A. Smythe"'
Autor:
David R. Anderson, Gian Paolo Morgano, Carole Bennett, Francesco Dentali, Charles W. Francis, David A. Garcia, Susan R. Kahn, Maryam Rahman, Anita Rajasekhar, Frederick B. Rogers, Maureen A. Smythe, Kari A.O. Tikkinen, Adolph J. Yates, Tejan Baldeh, Sara Balduzzi, Jan L. Brożek, Itziar Etxeandia- Ikobaltzeta, Herman Johal, Ignacio Neumann, Wojtek Wiercioch, Juan José Yepes-Nuñez, Holger J. Schünemann, Philipp Dahm
Publikováno v:
Blood Advances, Vol 3, Iss 23, Pp 3898-3944 (2019)
Abstract: Background: Venous thromboembolism (VTE) is a common source of perioperative morbidity and mortality.Objective: These evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about preventing
Externí odkaz:
https://doaj.org/article/8e3e6ffbfda94555b2d7712cd5d12dd4
Publikováno v:
Annals of Pharmacotherapy. 56:319-329
Objective To evaluate the literature on a potential dexamethasone–direct oral anticoagulant (DOAC) drug interaction and provide management considerations with COVID hypercoagulability. Data Sources A search of EMBASE, PubMed, and Google Scholar (Ja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc45161c3ddf6bed50d88897ecd19e7d
https://doi.org/10.1177/10600280211025042
https://doi.org/10.1177/10600280211025042
Autor:
Jane C. Moore, Jo-Ann I. Sheppard, Naveed Aslam, James W. Smith, Maureen A. Smythe, Theodore E. Warkentin, Mona A Ali, Ishac Nazy, Donald M. Arnold
Publikováno v:
American Journal of Hematology. 96:320-329
IgG-specific and polyspecific PF4-dependent enzyme-immunoassays (EIAs) have exceptionally high sensitivity (≥99%) for diagnosis of heparin-induced thrombocytopenia (HIT), a drug reaction caused by platelet-activating antibodies detectable by seroto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::823a4b2eebb57ed2c774827131499d21
https://doi.org/10.1002/ajh.26075
https://doi.org/10.1002/ajh.26075
Publikováno v:
Current Pharmacology Reports. 6:241-259
The introduction of newer anticoagulants requires clinicians to fully appreciate, interpret, and correctly apply the use of coagulation assays, such as the prothrombin time (PT), activated partial thromboplastin time (APTT), and anti-factor Xa assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa7b916f6406804903d1ac400be002ca
https://doi.org/10.1007/s40495-020-00232-7
https://doi.org/10.1007/s40495-020-00232-7
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 40:55-71
Patients with atrial fibrillation (AF) who suffer an acute ischemic stroke are at risk for both hemorrhagic transformation and recurrent ischemic stroke in the acute post-stroke period. Oral anticoagulants are recommended for secondary stroke prevent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d2a378e185f779d3431eeb414c5fe4e
https://doi.org/10.1002/phar.2345
https://doi.org/10.1002/phar.2345
Autor:
Nour Baalbaki, Maureen A. Smythe, Karissa Fritsch, Sean Mertz, John M. Koerber, Fatme Chehab, Anant Krishnan, Janet Hoffman
Publikováno v:
Thrombosis research. 206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93709df791179024e042320cb26afa57
https://pubmed.ncbi.nlm.nih.gov/34481221
https://pubmed.ncbi.nlm.nih.gov/34481221
Publikováno v:
Hospital Practice. 46:165-169
Objectives To identify patient characteristics, bleed management, and bleed outcomes in patients experiencing an apixaban major bleeding event and to identify opportunities to improve the safe use of apixaban. Methods This retrospective single health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1708a982d10af7cf2ce09bce3e6c6788
https://doi.org/10.1080/21548331.2018.1506675
https://doi.org/10.1080/21548331.2018.1506675
Autor:
Frederick B. Rogers, Herman Johal, Kari A.O. Tikkinen, Tejan Baldeh, Adolph J. Yates, Holger J. Schünemann, Francesco Dentali, Itziar Etxeandia Ikobaltzeta, Juan José Yepes-Nuñez, Charles W. Francis, David Anderson, Jan Brozek, Carole Bennett, Susan R. Kahn, David A. Garcia, Philipp Dahm, Anita Rajasekhar, Gian Paolo Morgano, Ignacio Neumann, Wojtek Wiercioch, Sara Balduzzi, Maryam Rahman, Maureen A. Smythe
Background:Venous thromboembolism (VTE) is a common source of perioperative morbidity and mortality.Objective:These evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about preventing VTE in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb1083e0c92c43a2d13a02f317a2de92
http://hdl.handle.net/11383/2097433
http://hdl.handle.net/11383/2097433
Publikováno v:
American Journal of Health-System Pharmacy. 73:s27-s48
Purpose The properties of three oral anticoagulant-specific reversal agents are reviewed, and guidance is presented to assist pharmacists in planning for the agents’ introduction to the market. Summary Idarucizumab, which received Food and Drug Adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5a5edf53038c5703d77edd67c7c860
https://doi.org/10.2146/ajhp150959
https://doi.org/10.2146/ajhp150959
Publikováno v:
Critical Care Medicine. 48:241-241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36d18a1f446f94ed645f7aa1eb3fc501
https://doi.org/10.1097/01.ccm.0000620428.63029.a5
https://doi.org/10.1097/01.ccm.0000620428.63029.a5